Alexis VA, Sonia V, Daniela S, Miguel G, Timothy H, Valentina F, Lisette L, Leonardo S (2021) Molecular analysis of full-length VP2 of Canine Parvovirus reveals antigenic drift in CPV-2b and CPV-2c variants in Central Chile. Anim (Basel) 11(8):2387

Google Scholar 

Ali RA, Wuescher LM, Worth RG (2015) Platelets: essential components of the immune system. Curr Trends Immunol 16:65–78

PubMed  PubMed Central  Google Scholar 

Alvarado-Dávila PG, Palacios-Ordoñez TE, Vallecillo-Maza A (2021). Canine Parvovirus type 2. Revista Ecuatoriana de Ciencia Animal. 5(2); 33–45.

Baldwin MR, Tepp WH, Przedpelski A, Pier CL, Bradshaw M, Johnson EA, Barbieri JT (2008) Subunit vaccine against the seven serotypes of botulism. Infect Immun 76(3):1314–1318

Article  CAS  PubMed  Google Scholar 

Banerjee K, Klasse PJ, Sanders RW, Pereyra F, Michael E, Lu M et al (2010) IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of env vaccines. AIDS Res Hum Retroviruses 26(4):445–458

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang D, Liu Y, Chen Y, Hu X, Burov A, Puzyr A et al (2020) Study of the immunogenicity of the VP2 protein of canine parvovirus produced using an improved baculovirus expression system. BMC Vet Res 18(1):202

Article  Google Scholar 

Cheng P, Miao Q, Huang J, Li J, Pu K (2020) Multiplex Optical Urinalysis for Early Detection of Drug-Induced kidney Injury. Anal Chem 21(8):6166–6172

Article  Google Scholar 

Collins AM (2016) IgG subclass co-expression brings harmony to the quartet model of murine IgG function. Immunol Cell Biol 94(10):949–954

Article  CAS  PubMed  Google Scholar 

Day MJ, Horzinek MC, Schultz RD, Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA) (2007) Guidelines for the vaccination of dogs and cats. Compiled by the Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA). J Small Anim Pract 48(9):528–541

Article  CAS  PubMed  PubMed Central  Google Scholar 

Decaro N, Buonavoglia C, Barrs VR (2020) Canine parvovirus vaccination and immunisation failures: are we far from disease eradication? Vet Microbiol 247:108760

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng H, Hu G-Q, Wang H-L, Liang M, Liang H, Guo H et al (2014) Canine Parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity. PLoS ONE 17(1):e79575

Article  Google Scholar 

Hurtado D, Báez P (2012) New perspective on canine parvovirus. Agric Anim Sci 1(2):46–60

Google Scholar 

Janeway CA Jr, Travers P, Walport M et al (2001) Immunobiology: the immune system in health and disease, 5th edn. Garland Science, New York

Google Scholar 

Joshi VG, Dighe VD, Thakuria D, Malik YS, Kumar S (2013) Multiple antigenic peptide (MAP): a synthetic peptide dendrimer for diagnostic, antiviral and vaccine strategies for emerging and re-emerging viral diseases. Indian J Virol 24(3):312–320

Article  PubMed  PubMed Central  Google Scholar 

Kalita P, Tripathi T (2022) Methodological advances in the design of peptide-based vaccines. Drug Discov Today 27(5):1367–1380

Article  CAS  PubMed  Google Scholar 

Kalita P, Padhi AK, Zhang KYJ, Tripathi T (2020) Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2. Microb Pathog 145:104236

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koury ST, Koury MJ, Bondurant MC, Caro J, Graber SE (1989) Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 1(2):645–651

Article  Google Scholar 

López de Turiso JA, Cortés E, Martínez C, Ruiz de Ybáñez R, Simarro I, Vela C, Casal I (1992) Recombinant vaccine for canine parvovirus in dogs. J Virol 66(5):2748–2753

Article  PubMed  PubMed Central  Google Scholar 

Malonis RJ, Lai JR, Vergnolle O (2020) Peptide-based vaccines: current Progress and Future challenges. Chem Rev 120(6):3210–3229

Article  CAS  PubMed  Google Scholar 

Momtazi-Borojeni AA, Banach M, Tabatabaei SA, Sahebkar A (2023) Preclinical toxicity assessment of a peptide-based antiPCSK9 vaccine in healthy mice. Biomed Pharmacother.;158(114170)

Parini V, Surti MW, Kim LMT (2022) Suresh Kumar Kailasa, Arvind Kumar Mungray, Jong Pil Park, Tae Jung Park. Progress on dot-blot assay as a promising analytical tool: detection from molecules to cells. Trends Analyt Chem 157(116736):116736

Google Scholar 

Paul B, Alam J, Hossain MMK, Hoque SF, Bappy MNI, Akter H, Ahmed N, Akter M, Ali Zinnah M, Das S, Mia MM, Parvej MS, Sarkar S, Ghosh H, Hasan M, Ashour HM, Rahman MM (2023) Immunoinformatics for Novel Multi-epitope Vaccine Development in Canine Parvovirus infections. Biomedicines 11(8):2180

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pognan F, Beilmann M, Boonen HCM, Czich A, Dear G, Hewitt P, Mow T, Oinonen T, Roth A, Steger-Hartmann T, Valentin JP, Van Goethem F, Weaver RJ, Newham P (2023) The evolving role of investigative toxicology in the pharmaceutical industry. Nat Rev Drug Discov 22(4):317–335

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quino QR, Rimac BR, Luna EL, Maturrano HL, Rosadio AR (2018) Detection of canine parvovirus type 2 (CPV-2) in dogs from Metropolitan Lima, Peru, by PCR. Rev Investig Vet Peru 29(3):972–979

Article  Google Scholar 

Quishpe Ocampo (2020) O Determination of the prevalence and risk factors associated with canine parvovirus in records of Lucky Veterinary Hospital during the period 2014–2019. Quito: UCE

Sehata G, Sato H, Yamanaka M, Takahashi T, Kainuma R, Igarashi T, Oshima S, Noro T, Oishi E (2017) Substitutions at residues 300 and 389 of the VP2 capsid protein serve as the minimal determinant of attenuation for canine parvovirus vaccine strain 9985-46. J Gen Virol 98(11):2759–2770

Article  CAS  PubMed  Google Scholar 

Silva LMN, Santos MR, Carvalho JA, Carvalho OV, Favarato ES, Fietto JLR, Silva-Júnior A (2022) Molecular analysis of the full-length VP2 gene of Brazilian strains of canine parvovirus 2 shows genetic and structural variability between wild and vaccine strains. Virus Res 313:198746

Article  CAS  PubMed  Google Scholar 

Silva-Santana G, Bax JC, Fernandes DCS, Bacellar DTL, Hooper C, Dias AASO et al (2020) Clinical hematological and biochemical parameters in Swiss, BALB/c, C57BL/6 and B6D2F1 Mus musculus. Anim Model Exp Med 3(4):304–315

Article  Google Scholar 

Singh M, Tripathi P, Singh S, Sachan M, Chander V, Sharma GK et al (2021) Identification and characterization of DNA aptamers specific to VP2 protein of canine parvovirus. Appl Microbiol Biotechnol 105(23):8895–8906

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skwarczynski M, Toth I (2016) Peptide-based synthetic vaccines. Chem Sci 7(2):842–854

Article  CAS  PubMed  Google Scholar 

Spibey N, Greenwood NM, Sutton D, Chalmers WSK, Tarpey I (2008) Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus. Vet Microbiol 128(1–2):48–55

Article  CAS  PubMed  Google Scholar 

Tonomura Y, Yamamoto E, Kondo C, Itoh A, Tsuchiya N, Uehara T, Baba T (2009) Amphotericin B-induced nephrotoxicity: characterization of blood and urinary biochemistry and renal morphology in mice. Hum Exp Toxicol 28(5):293–300

Article  CAS  PubMed  Google Scholar 

Visciano ML, Tagliamonte M, Tornesello ML, Buonaguro FM, Buonaguro L (2012) Effects of adjuvants on IgG subclasses elicited by virus-like particles. J Transl Med 5:10:4

Article  Google Scholar